Research Topics
| Scott W MenziesSummaryAffiliation: New South Wales Country: Australia Publications
| Collaborators
|
Detail Information
Publications
Is sun exposure a major cause of melanoma? YesScott W Menzies
University of Sydney, Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, 2050 NSW, Australia
BMJ 337:a763. 2008
Cutaneous melanoma: making a clinical diagnosis, present and futureScott W Menzies
Sydney Melanoma Diagnostic Center, Cancer Center, University of Sydney, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia
Dermatol Ther 19:32-9. 2006..Currently, other noninvasive diagnostic techniques, such as in vivo confocal scanning laser microscopy, are reserved for clinical research settings...- The performance of SolarScan: an automated dermoscopy image analysis instrument for the diagnosis of primary melanomaScott W Menzies
Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
Arch Dermatol 141:1388-96. 2005..To describe the diagnostic performance of SolarScan (Polartechnics Ltd, Sydney, Australia), an automated instrument for the diagnosis of primary melanoma... - UV light from 290 to 325 nm, but not broad-band UVA or visible light, augments the formation of melanocytic nevi in a guinea-pig model for human neviScott W Menzies
Sydney Melanoma Diagnostic Centre, Sydney Cancer Institute, Royal Prince Alfred Hospital and Faculty of Medicine, University of Sydney, NSW 2006, Australia
J Invest Dermatol 123:354-60. 2004..Furthermore, because there was a significant decrease in nevi/animal receiving the full solar spectrum compared with the UVB group, it is possible that broad-band UVA and or visible light may be inhibitory wavebands for nevi induction... - Dermoscopic evaluation of amelanotic and hypomelanotic melanomaScott W Menzies
Faculty of Medicine, University of Sydney, Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia
Arch Dermatol 144:1120-7. 2008..To determine the predictive dermoscopic features of amelanotic and hypomelanotic melanoma... - The impact of in vivo reflectance confocal microscopy on the diagnostic accuracy of lentigo maligna and equivocal pigmented and nonpigmented macules of the facePascale Guitera
Sydney Melanoma Diagnostic Centre and Dermatology Department, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
J Invest Dermatol 130:2080-91. 2010..In a test set of 29 LMs and 44 BMs, the OR for LM was 60.7 (confidence interval: 11.9-309) (93% sensitivity, 82% specificity)... - In vivo confocal microscopy for diagnosis of melanoma and basal cell carcinoma using a two-step method: analysis of 710 consecutive clinically equivocal casesPascale Guitera
Department of Dermatology, Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia
J Invest Dermatol 132:2386-94. 2012..RCM is a highly accurate non-invasive technique for BCC diagnosis. Good diagnostic accuracy was achieved also for MM diagnosis, although rare variants of melanocytic tumors may limit the strict application of the algorithm... - Dermoscopy and its role in diagnosing melanocytic lesions: a guide for pathologistsKerry A Crotty
Melanoma and Skin Cancer Research Institute, University of Sydney, NSW, Australia
Pathology 36:470-7. 2004..Several non-melanocytic pigmented lesions can be diagnosed with dermoscopy, including pigmented basal cell carcinoma, seborrhoeic keratoses, haemangioma and lichen planus-like keratosis... - Variables predicting change in benign melanocytic nevi undergoing short-term dermoscopic imagingScott W Menzies
Discipline of Dermatology, Sydney Medical School, University of Sydney and Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, NSW, 2050 Australia
Arch Dermatol 147:655-9. 2011..To determine whether certain patient demographics are associated with poorer specificity for the diagnosis of melanoma in nevi undergoing short-term sequential digital dermoscopic imaging... - Assessment of the optimal interval for and sensitivity of short-term sequential digital dermoscopy monitoring for the diagnosis of melanomaDavide Altamura
Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
Arch Dermatol 144:502-6. 2008..To determine whether 6 weeks could replace 3 months for short-term sequential digital dermoscopy imaging (ST-SDDI) of suspicious melanocytic lesions and determine the proportion of melanomas missed... - Morphologic features of melanophages under in vivo reflectance confocal microscopyPascale Guitera
Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales 2050, Australia
Arch Dermatol 146:492-8. 2010..To determine morphologic features of melanophages under in vivo reflectance confocal microscopy (RCM) and to highlight morphologic features that are important in distinguishing melanophages from melanocytes... - Key points in the dermoscopic diagnosis of hypomelanotic melanoma and nodular melanomaFergal J Moloney
Discipline of Dermatology, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia
J Dermatol 38:10-5. 2011.... - In vivo reflectance confocal microscopy enhances secondary evaluation of melanocytic lesionsPascale Guitera
Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre and Dermatology Department, Royal Prince Alfred Hospital, Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
J Invest Dermatol 129:131-8. 2009..3-94.5) compared with dermoscopy (specificity 39%, 95% CI: 23.7-56.2). Secondly, the RCM method classified 100% of the non-biopsied control nevi population as benign... - Dermoscopy of pigmented basal cell carcinomaScott W Menzies
Sydney Melanoma Unit, Royal Prince Alfred Hospital, Camperdown, Australia
Clin Dermatol 20:268-9. 2002 - Automated diagnostic instruments for cutaneous melanomaMalene E Vestergaard
Department of Dermatology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
Semin Cutan Med Surg 27:32-6. 2008..Other image based nonclinic studies and studies comparing clinical management as the endpoint rather than diagnosis are also reviewed... - Enhanced survival in patients with multiple primary melanomaAnna Doubrovsky
Sydney Melanoma Unit, Melanoma and Skin Cancer Research Institute, Department of Surgery, University of Sydney, Sydney, Australia
Arch Dermatol 139:1013-8. 2003..To calculate survival probabilities of patients with 3 or more multiple primary melanomas... - Results of a nationwide dermoscopy survey investigating the prevalence, advantages and disadvantages of dermoscopy use among Australian dermatologistsSupriya S Venugopal
Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown NSW, Australia
Australas J Dermatol 52:14-8. 2011..The primary objective of this survey was to assess the prevalence of use of dermoscopy by Australian dermatologists. The secondary objective was to understand the perceived advantages and disadvantages of dermoscopy use... - Technologies for the diagnosis of primary melanoma of the skinScott W Menzies
Med J Aust 185:533-4. 2006..There is now an inexpensive first-line approach for diagnosing pigmented skin lesions... - Why perform dermoscopy? The evidence for its role in the routine management of pigmented skin lesionsScott W Menzies
Arch Dermatol 142:1211-2. 2006 - Dermoscopy of pigmented skin lesions: results of a consensus meeting via the InternetGiuseppe Argenziano
Department of Dermatology, Second University of Naples, Italy
J Am Acad Dermatol 48:679-93. 2003..53). CONCLUSION: The virtual Consensus Net Meeting on Dermoscopy represents a valid tool for better standardization of the dermoscopic terminology and, moreover, opens up a new territory for diagnosing and managing pigmented skin lesions... - Autonomous histopathological regression of primary tumours associated with specific immune responses to cancer antigensFarid H Saleh
Department of Human Morphology, Faculty of Medicine, The American University of Beirut, PO Box 11 0236, Beirut, Lebanon FaridS l
J Pathol 200:383-95. 2003..No similar effects were observed with two other melanoma antigens, gp100 and CD63. Thus, in two groups of human melanoma patients, evidence is provided for histopathological tumour regression associated with cancer immune surveillance... - Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanomaPeter Hersey
Oncology and Immunology Unit, Room 443, David Maddison Clinical Sciences Building, Cnr King and Watt Streets, 2300, Newcastle, NSW, Australia
Cancer Immunol Immunother 53:125-34. 2004..DTH responses to autologous lysates appear useful predictors of clinical responses, but further work is needed to identify other measures associated with clinical responses... - Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanomaPeter Hersey
Oncology and Immunology Unit, Room 443, David Maddison Clinical Sciences Building, King and Watt Streets, Newcastle, NSW, 2300, Australia
Cancer Immunol Immunother 54:208-18. 2005.... - Time to diagnosis of melanoma: same trend in different continentsAndreas Blum
Department of Dermatology, University of Tuebingen, Tuebingen, Germany
J Cutan Med Surg 11:137-44. 2007..Patients and physicians both play an important role in the diagnosis of malignant melanoma...